Selectivity of dihydropyridines for cardiac L-type and sympathetic N-type Ca2+ channels

European Journal of Pharmacology

Volumn 373, Issue 1, 1999, Pages 93-100

  Uneyama, Hisayuki ^a   Uchida, Hirohisa ^a   Konda, Tomoyuki ^a   Yoshimoto, Ryota ^a   Akaike, Norio ^b  

^a YRP Mobile Telecommunications Key   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Ca2+ channel; Cilnidipine (FRC 8653); Dihydropyridine; Sympathetic neuron; Ventricular myocyte

Indexed keywords

AMLODIPINE; BENIDIPINE; CALCIUM CHANNEL; CILNIDIPINE; DIHYDROPYRIDINE DERIVATIVE; MANIDIPINE; NICARDIPINE; NIFEDIPINE; NILVADIPINE; NITRENDIPINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HEART MUSCLE CELL; MALE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; STEADY STATE; SYMPATHETIC NERVE CELL;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; DIHYDROPYRIDINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; HEART VENTRICLES; MALE; MEMBRANE POTENTIALS; MYOCARDIUM; NEURONS; RATS; RATS, WISTAR; SYMPATHETIC NERVOUS SYSTEM;

EID: 0033053092     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00237-X     Document Type: Article

References (28)

1. 2+ channel in rat dorsal root ganglion neurons. J. Pharmacol. Exp. Ther. 280:1997;1184-1191.
2. Furberg C.D., Psaty B.M., Meyer J.V. Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation. 92:1995;1326-1331.
3. 2+ channels by amlodipine. Br. J. Pharmacol. 121:1997;1136-1140.
4. Goldbourt U., Behar S., Reicher-Reiss H., Zion M., Mandelzweig L., Kaplinsky E. Early administration of nifedipine in suspected acute myocardial infarction: the secondary prevention reinfarction Israel nifedipine trial 2 study. Arch. Intern. Med. 153:1993;345-353.
5. Hamill O.P., Marty A., Neher E., Sakmann B., Sigworth F.J. Improved patch-clamp technique for high resolution current recording from cells and cell-free membrane patch. Pfluegers Arch. Eur. J. Physiol. 391:1981;85-100.
6. Haria M., Wagstaff A.J. Amlodipine. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disease. Drugs. 50:1995;560-586.
7. 2+ channels in evoked release of norepinephrine from sympathetic neurons. Science. 239:1988;57-61.
8. Hosono M., Fujii S., Himura T., Watanabe K., Hayashi Y., Ohnishi H., Takata Y., Kato H. Inhibitory effect of cilnidipine on vascular sympathetic neurotransmission and subsequent vasoconstriction in spontaneously hypertensive rats. Jpn. J. Pharmacol. 69:1995;127-134.
9. Hosono M., Himura T., Watanabe K., Hayashi Y., Ohnishi H., Takata Y., Kato H. Inhibitory effect of cilnidipine on pressor response to acute cold stress in spontaneously hypertensive rats. Jpn. J. Pharmacol. 69:1995;119-125.
10. 2+ channels in rat CNS neurones. NeuroReport. 6:1995;1621-1624.
11. Kass R.S., Arena J.P. Influence of pHo on calcium channel block by amlodipine, a charged dihydropyridine compound. J. Gen. Physiol. 93:1989;1109-1127.
12. Kass R.S., Arena J.P. Block of L-type calcium channels by charged dihydropyridines. Selectivity to side of application and calcium. J. Gen. Physiol. 98:1991;63-75.
13. Kimichi, A., Lewis, B.S., 1991. Calcium antagonists and the management of heart failure. In: Lewis, B.S., Kimichi, A. (Eds.), Heart Failure: Mechanisms and Management. Berlin, Springer, pp. 281-292.
14. Michalewicz L., Messerli F.H. Cardiac effects of calcium antagonists in systemic hypertension. Am. J. Cardiol. 79:1997;39-46.
15. Muller J.E., Tofler G.H., Stone P.H. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation. 79:1989;733-743.
16. Murase K., Randic M., Shirasaki T., Nakagawa T., Akaike N. Serotonin suppresses N-methyl-D-aspartate response in acutely isolated spinal dorsal horn neurons of the rat. Brain Res. 525:1990;84-91.
17. Nakashima M., Kou M., Hashitani H., Chen G., Ono H., Kuriyama H., Suzuki H. Action of FRC-8653 on smooth muscle cells of the rabbit mesenteric artery. Jpn. J. Pharmacol. 57:1991;51-61.
18. 2+ current recorded from the rabbit basilar artery. Circ. Res. 67:1990;993-1006.
19. Packer M., O'Connor C.M., Ghali J.K., Pressler M.L., Carson P.E., Belkin R.N., Miller A.B., Neuberg G.W., Frid D., Wertheimer J.H., Cropp A.B., DeMets D.L. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective randomized amlodipine survival evaluation study group. N. Engl. J. Med. 335:1996;1107-1114.
20. Saihara S., Sumio M., Hosono N., Hayashi Y., Kitamura Y., Hashimoto S. Effect of FRC-8653 (Cilnidipine) on blood pressure changes during the cold pressor test. Jpn. Pharmacol. Ther. 21:1993;271-276.
21. Sun J., Triggle D.J. Calcium channel antagonists: cardiovascular selectivity of action. J. Pharmacol. Exp. Ther. 274:1995;419-426.
22. + current in guinea-pig heart cells. Am. J. Physiol. 253:1987;H1321-H1324.
23. Uneyama H., Munakata M., Akaike N. 5-HT response of rat hippocampal pyramidal cell bodies. NeuroReport. 3:1992;633-636.
24. 2+ current by cilnidipine (FRC-8653) in acutely dissociated rat sympathetic neurones. Br. J. Pharmacol. 122:1997;37-42.
25. Uneyama H., Uchida H., Yoshimoto R., Ueno S., Inoue K., Akaike N. Effects of a novel antihypertensive drug, cilnidipine, on the catecholamine secretion from the differentiated PC12 cells. Hypertension. 31:1998;1195-1199.
26. Walsh R.A. The effects of calcium-entry blockade on left ventricular systolic and diastolic function. Circulation. 75:1987;V43-V55.
27. 2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes. Mol. Pharmacol. 35:1988;541-552.
28. Yoshimoto R., Dohmoto H., Yamada K., Goto A. Prolonged inhibition of vascular contraction and calcium influx by the novel 1,4-dihydropyridine calcium antagonist cinaldipine. Jpn. J. Pharmacol. 56:1991;225-229.